Shooting Cancer Congress Highlights: ESMO 2026
ESMO 2026: At the ESMO Congress 2026 in Madrid, many of the most relevant results depended on a molecular marker used to select patients, define the therapeutic target or design the treatment itself. Each of these steps involves oncologists, molecular biologists and pathologists. This issue presents a curated selection of highlights in which biomarker testing […]